Disorders of androgen action

Seminars in Reproductive Medicine

Volumn 20, Issue 3, 2002, Pages 217-227

  Sultan, Charles ^a   Lumbroso, Serge ^a   Paris, Françoise ^a   Jeandel, Claire ^a   Terouanne, B ^a   Belon, Charles ^a   Audran, F ^a   Poujol, N ^a   Georget, V ^a   Gobinet, J ^a   Jalaguier, S ^a   Auzou, G ^a   Nicolas, J C ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

5 reductase deficiency; Ambiguous genitalia; Androgen insensitivity syndrome

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CHORIONIC GONADOTROPIN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE ENANTATE;

AGE; ANDROGEN INSENSITIVITY SYNDROME; ANDROGEN METABOLISM; BREAST DEVELOPMENT; CLITORIS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENZYME DEFICIENCY; FEMALE GENITAL SYSTEM; FOLLOW UP; GENDER IDENTITY DISORDER; GENE MUTATION; GENITAL MALFORMATION; GENITAL SYSTEM DISEASE; GONADECTOMY; HAIR GROWTH; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOSPADIAS; LUTEINIZING HORMONE RELEASE; MALE; MALE PSEUDOHERMAPHRODITISM; MUSCLE MASS; PENIS; PHENOTYPE; PRIMARY AMENORRHEA; PSYCHOLOGICAL ASPECT; RECEPTOR GENE; REVIEW; SCROTUM DISORDER; SKIN FIBROBLAST; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

ANDROGEN-INSENSITIVITY SYNDROME; ANDROGENS; FEMALE; GONADAL DYSGENESIS; HUMANS; MALE; METABOLISM, INBORN ERRORS; PSEUDOHERMAPHRODITISM; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 18644376554     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35386     Document Type: Review

References (47)

1. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5αlpaha-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science 1974;186:1213-1216
2. Wilson JD, Griffin JE, Russel DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993;14:577-593
3. Imperato-McGinley J, Zhu YS. Androgens and male physiology: The syndrome of 5 alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002. In press
4. Russel DW, Wilson JD. Steroid 5 alpha-reductase: Two genes/two enzymes. Annu Rev Biochem 1994;63:25-61
5. Andersson S, Berman DM, Jenkins EP, Russel DW. Deletion of steroid 5αlpha-reductase-2 gene in male pseudohermaphroditism. Nature 1991;354:159-161
6. Cai LQ, Zhu YS, Katz MD, et al. 5αlpha-reductase-2 gene mutation in the Dominican Republic. J Clin Endocrinol Metab 1996;81:1730-1735
7. Mendonca BB, Inacio M, Costa EM, et al. Male pseudohermaphroditism due to steroid 5αlpha-reductase 2 deficiency: Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 1996;75:64-76
8. Sultan C, Lobaccaro JM, Lumbroso S, Poujol N. Disorders of sexual differentiation: Recent molecular and clinical advances. In: Kelnar CJH, ed. Bailliere's Clinical Paediatrics. London: Baillière Tindall; 1996:221-243
9. Prader A. Der genitalbefund beim pseuhermaphroditismus feminus des kongenitalen adrenogenitalen syndroms. Helv Paediatr Acta 1954;9:231-248
10. Quigley CA, Debellis A, Marschke KB, et al. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321
11. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): A clinicopathological study of 43 cases. Int J Gynecol Pathol 1991;10:126-144
12. Griffin JE. Androgen resistance: The clinical and molecular spectrum. N Engl J Med 1992;326:611-618
13. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. Genetic basis of endocrine disease 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993;76:17-23
14. Batch JA, Evans BA, Hughes IA, Patterson MN. Mutations of the androgen receptor gene identified in perineal hypospadias. J Med Genet 1993;30:198-201
15. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr 1997;156:7-14
16. Rey RA, Belville C, Nihoul-Fekete C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab 1999;84:627-631
17. Nirdé P, Georget V, Térouanne B, et al. Quantification of androgen receptor messenger RNA from genital skin fibroblasts by reverse transcription-competitive polymerase chain reaction. J Steroid Biochem Mol Biol 1998;66:35-43
18. Chang C, Kokontis J, Liao S. Molecular cloning of human and rat cDNA encoding androgen receptors. Science 1988;240:324-326
19. Lubahn DB, Joseph DR, Sar M, et al. The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988;2:1265-1275
20. Gottlieb B, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. Update of the androgen receptor gene mutations database. Hum Mutat 1999;14:103-114
21. Lumbroso S, Lobaccaro JM, Belon C, et al. Molecular pre-natal exclusion of Reifenstein syndrome. Eur J Endocrinol 1994;130:327-332
22. Boehmer AL, Brinkmann AO, Niermeijer MF, et al. Germline and somatic mosaicism in the androgen insensitivity syndrome: Implications for genetic counseling [letter]. Am J Hum Genet 1997;60:1003-1006
23. Negro-Vilar A. Selective androgen receptor modulators (SARMs): A novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999;84:3459-3462
24. Georget V, Terouanne B, Lumbroso S, Nicolas JC, Sultan C. Trafficking of androgen receptor mutants fused to green fluorescent protein: A new investigation of partial androgen insensitivity syndrome. J Clin Endocrinol Metab 1998 83:3597-3603
25. Georget V, Nicolas JC, Sultan C. La Green Fluorescent Protein: Application à la dynamique intracellulaire des récepteurs stéroïdiens. Med/Sci 1999;15:45-55
26. Lobaccaro JM, Poujol N, Chiche L, et al. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: Application for the study of two mutations. Mol Cell Endocrinol 1996;116:137-147
27. Wurtz JM, Bourguet W, Renaud JP, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 1996;3:87-94
28. Poujol N, Wurtz JM, Tahiti B, et al. Specific recognition of androgens by their nuclear receptor: A structure-function study. J Biol Chem 2000;275:24022-24031
29. Rodien P, Mebarki F, Mowszowicz I, et al. Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 1996;81:2994-2998
30. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset: A sex-linked recessive trait. Neurology 1968;18:671-680
31. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck K. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79
32. Cummings CJ, Zoghbi HY. Fourteen and counting: Unraveling trinucleotide repeat diseases. Hum Mol Genet 2000;9:909-916
33. Paulson HL. Toward an understanding of polyglutamine neurodegeneration. Brain Pathol 2000;10:293-299
34. Vedscholte J, Ris-Stalpers C, Kuiper GGJM, et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 1990;173:534-540
35. Newmark JR, Hardy DO, Tonb DC, et al. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A 1992;89:6319-6323
36. Sultan C, Terouanne B, Tahiti B, et al. [Androgen-independent prostate carcinoma and androgen-receptor: Recent progress in molecular genetics]. Bull Cancer 1999;86:618-621
37. Wooster R, Mangion J, Eeles R, et al. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 1992;2:132-134
38. Lobaccaro J, Lumbroso S, Belon C, et al. Male breast cancer and androgen receptor gene. Nat Genet 1993;5:109-110
39. Poujol N, Lobaccaro JM, Chiche L, Lumbroso S, Sultan C. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol 1997;130:43-51
40. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-1940
41. Giovannucci E, Stampfer MJ, Krithivas K, et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer [published erratum appears in Proc Natl Acad Sci U S A 1997;94:8272]. Proc Natl Acad Sci U S A 1997;94:3320-3323
42. Correa-Cerro L, Wohr G, Haussler J, et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 1999;7:357-362
43. Dowsing AT, Yong EL, Clark M, et al. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 1999;354:640-643
44. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 1997;82:3777-3782
45. Rebbeck TR, Kantoff PW, Krithivas K, et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 1999;64: 1371-1377
46. Vottero A, Stratakis CA, Ghizzoni L, et al. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: Skewing of X-chromosome inactivation. J Clin Endocrinol Metab 1999;84:1091-1095
47. Sawaya ME, Shalita AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998;3:9-15